Bluebird Historical Cash Flow
| BLUE Stock | USD 0.49 0.01 2.08% |
Analysis of Bluebird Bio cash flow over time is an excellent tool to project Bluebird bio future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Stock Based Compensation of 18.5 M or Begin Period Cash Flow of 288.5 M as it is a great indicator of Bluebird Bio ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Bluebird bio latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Bluebird bio is a good buy for the upcoming year.
Bluebird |
About Bluebird Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Bluebird balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Bluebird's non-liquid assets can be easily converted into cash.
Bluebird Bio Cash Flow Chart
Add Fundamental
Stock Based Compensation
Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Capital Expenditures
Capital Expenditures are funds used by Bluebird bio to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Bluebird Bio operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.Total Cashflows From Investing Activities
The net amount of cash used in or generated from a company's investment activities, such as purchasing or selling assets, during a reporting period.Most accounts from Bluebird Bio's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Bluebird bio current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bluebird bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment. For information on how to trade Bluebird Stock refer to our How to Trade Bluebird Stock guide.At present, Bluebird Bio's Begin Period Cash Flow is projected to increase significantly based on the last few years of reporting. The current year's Other Cashflows From Financing Activities is expected to grow to about 24.3 M, whereas Free Cash Flow is forecasted to decline to (256.3 M).
Bluebird Bio cash flow statement Correlations
Click cells to compare fundamentals
Bluebird Bio Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Bluebird Bio cash flow statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change In Cash | (35.4M) | (8.0M) | (167.0M) | (48.2M) | 116.2M | 122.0M | |
| Stock Based Compensation | 160.6M | 156.6M | 127.9M | 35.2M | 19.4M | 18.5M | |
| Free Cash Flow | (640.6M) | (499.3M) | (658.6M) | (366.2M) | (244.1M) | (256.3M) | |
| Change In Working Capital | 46.1M | (28.9M) | 18.0M | (39.1M) | (49.7M) | (47.2M) | |
| Begin Period Cash Flow | 417.1M | 381.7M | 373.7M | 206.7M | 158.4M | 288.5M | |
| Other Cashflows From Financing Activities | 9.9M | 22.6M | (94.0M) | 25.7M | 23.2M | 24.3M | |
| Depreciation | 17.4M | 19.4M | 19.6M | 5.0M | 28.5M | 30.0M | |
| Other Non Cash Items | (8.3M) | (6.0M) | 17.6M | (87.4M) | (36.9M) | (35.1M) | |
| Capital Expenditures | 76.3M | 29.0M | 23.0M | 13.2M | 9.1M | 8.6M | |
| Total Cash From Operating Activities | (564.4M) | (470.4M) | (635.6M) | (353.0M) | (235.0M) | (246.8M) | |
| Net Income | (789.6M) | (618.7M) | (819.4M) | (266.6M) | (211.9M) | (222.5M) | |
| Total Cash From Financing Activities | 21.2M | 546.7M | (94.0M) | 54.3M | 196.2M | 323.5M | |
| End Period Cash Flow | 381.7M | 373.7M | 206.7M | 158.4M | 274.6M | 309.7M | |
| Total Cashflows From Investing Activities | 507.8M | (84.3M) | 562.6M | 250.5M | 288.0M | 302.4M | |
| Sale Purchase Of Stock | 681.1M | 21.2M | 546.7M | 80.3M | 92.4M | 87.8M | |
| Cash And Cash Equivalents Changes | (355.2M) | (35.4M) | (8.0M) | (167.0M) | (150.3M) | (142.8M) | |
| Cash Flows Other Operating | (21.4M) | (11.7M) | 3.4M | (42.2M) | (38.0M) | (36.1M) | |
| Other Cashflows From Investing Activities | (623.7M) | (5.2M) | 102M | 101.8M | 117.3M | 123.2M | |
| Change To Netincome | 149.6M | 150.6M | 146.1M | (52.3M) | (60.1M) | (57.1M) | |
| Change To Liabilities | 1.6M | 41.4M | 69.9M | (25.1M) | 9.3M | 0.0 | |
| Investments | 584.1M | (55.4M) | 475.3M | 250.5M | 155.0M | 162.7M | |
| Change To Operating Activities | 39.2M | (18.6M) | 27.1M | (31.0M) | (27.9M) | (26.5M) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| MSFT | Microsoft | |
| F | Ford Motor | |
| CRM | Salesforce |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bluebird bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment. For information on how to trade Bluebird Stock refer to our How to Trade Bluebird Stock guide.You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bluebird Bio. If investors know Bluebird will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bluebird Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.30) | Revenue Per Share 0.357 | Quarterly Revenue Growth 1.337 | Return On Assets (0.36) | Return On Equity (1.87) |
The market value of Bluebird bio is measured differently than its book value, which is the value of Bluebird that is recorded on the company's balance sheet. Investors also form their own opinion of Bluebird Bio's value that differs from its market value or its book value, called intrinsic value, which is Bluebird Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bluebird Bio's market value can be influenced by many factors that don't directly affect Bluebird Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bluebird Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bluebird Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bluebird Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.